Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non-Small Cell Lung Cancer: A Single Institution Database Analysis.
暂无分享,去创建一个
H. Kenmotsu | T. Naito | A. Ono | H. Murakami | Toshiaki Takahashi | Y. Gon | K. Wakuda | Tetsuo Shimizu | Haruki Kobayashi | N. Mamesaya | R. Ko